- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/10 - Condensed 1,2,4-triazinesHydrogenated condensed 1,2,4-triazines
Patent holdings for IPC class C07D 253/10
Total number of patents in this class: 31
10-year publication summary
|
3
|
3
|
0
|
2
|
0
|
2
|
2
|
2
|
1
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer HealthCare LLC | 1354 |
2 |
| Takeda Pharmaceutical Company Limited | 2713 |
2 |
| Japan Tobacco Inc. | 3597 |
2 |
| Symrise AG | 1722 |
2 |
| Bristol-myers Squibb Company | 4898 |
1 |
| LG Display Co., Ltd. | 13469 |
1 |
| The Regents of the University of California | 19918 |
1 |
| Merck Sharp & Dohme Corp. | 2194 |
1 |
| Dow Global Technologies LLC | 10363 |
1 |
| Abbvie Inc. | 1800 |
1 |
| OSRAM Opto Semiconductors GmbH | 3312 |
1 |
| Alios BioPharma, Inc. | 66 |
1 |
| BioCryst Pharmaceuticals, Inc. | 175 |
1 |
| Incyte Corporation | 1024 |
1 |
| SRI International | 1013 |
1 |
| Stichting Maastricht Radiation Oncology "maastro-clinic" | 17 |
1 |
| Trustees of Dartmouth College | 1085 |
1 |
| Universite de Montpellier | 985 |
1 |
| University of Greenwich | 71 |
1 |
| Istanbul Medipol Universitesi | 177 |
1 |
| Other owners | 7 |